# Single Patient Investigational Treatment for Cree Leukoencephalopathy

> **NCT07300397** · NA · ACTIVE_NOT_RECRUITING · sponsor: **McGill University Health Centre/Research Institute of the McGill University Health Centre** · enrollment: 1 (estimated)

## Conditions studied

- Cree Leukoencephalopathy

## Interventions

- **DRUG:** Fosigotifator

## Key facts

- **NCT ID:** NCT07300397
- **Lead sponsor:** McGill University Health Centre/Research Institute of the McGill University Health Centre
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2029-01-03
- **Final completion:** 2029-01-03
- **Target enrollment:** 1 (ESTIMATED)
- **Last updated:** 2026-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300397

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300397, "Single Patient Investigational Treatment for Cree Leukoencephalopathy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07300397. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*